title: Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases.
authors.affiliation: Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, Texas.|Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
authors.forename: Zi
authors.initials: Z
authors.lastname: Chen
authors.affiliation: Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.affiliation: Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Amy
authors.initials: A
authors.lastname: Rich
authors.affiliation: Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Guilin
authors.initials: G
authors.lastname: Tang
authors.affiliation: Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Shimin
authors.initials: S
authors.lastname: Hu
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D023981:Sarcoma, Myeloid / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D047428:Protein Kinase Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D008558:Melphalan; D011241:Prednisone